| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2722 | |||||||||||||||||||||||
| Submitter : | Mrs. Cathy McLaughlin | Date & Time: | 12/07/2006 11:12:01 | |||||||||||||||||||||
| Organization : | Mrs. Cathy McLaughlin | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I disagree with the FDA's approval on aborted fetal cell lines in vaccinations, this will be a terribly dilemma for our generation and those to come. It will also affect the welfare of our society and world because there will be people denying vaccinations on moral principles. This is wrong and should be reconsidered. | ||||||||||||||||||||||||